[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2010067986A2 - Composition for controlling gastrointestinal tract movement - Google Patents

Composition for controlling gastrointestinal tract movement Download PDF

Info

Publication number
WO2010067986A2
WO2010067986A2 PCT/KR2009/007215 KR2009007215W WO2010067986A2 WO 2010067986 A2 WO2010067986 A2 WO 2010067986A2 KR 2009007215 W KR2009007215 W KR 2009007215W WO 2010067986 A2 WO2010067986 A2 WO 2010067986A2
Authority
WO
WIPO (PCT)
Prior art keywords
composite composition
intestinal motility
motility disorder
controlling
movement
Prior art date
Application number
PCT/KR2009/007215
Other languages
French (fr)
Korean (ko)
Other versions
WO2010067986A3 (en
Inventor
박영준
조관형
최용규
Original Assignee
삼일제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 삼일제약주식회사 filed Critical 삼일제약주식회사
Publication of WO2010067986A2 publication Critical patent/WO2010067986A2/en
Publication of WO2010067986A3 publication Critical patent/WO2010067986A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides a novel composite composition for controlling gastrointestinal tract movement comprising an enkephaline receptor agonist and a prokinetic agent. The composite composition provided according to the present invention is a general purpose composite composition for controlling movement of the upper and lower gastrointestinal tracts that enables improved movement controlling capabilities of the upper and lower gastrointestinal tracts in a complementary fashion, based on mutually different mechanisms of an enkephaline receptor agonist and a prokinetic agent. Thus, this is a novel composite composition that exhibits inclusive and effective therapeutic actions on various diseases including functional gastrointestinal disturbance, constipation, and irritable bowel syndrome as well as diabetic intestinal motility disorder, intestinal motility disorder caused by chemotherapy, ileus caused by intestinal motility disorder, and intestinal motility disorder in myotonic dystrophy patients.
PCT/KR2009/007215 2008-12-08 2009-12-04 Composition for controlling gastrointestinal tract movement WO2010067986A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080124068A KR100991032B1 (en) 2008-12-08 2008-12-08 Novel Pharmaceutical Composition For Effective Control Of GI Motility
KR10-2008-0124068 2008-12-08

Publications (2)

Publication Number Publication Date
WO2010067986A2 true WO2010067986A2 (en) 2010-06-17
WO2010067986A3 WO2010067986A3 (en) 2010-09-10

Family

ID=42243174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007215 WO2010067986A2 (en) 2008-12-08 2009-12-04 Composition for controlling gastrointestinal tract movement

Country Status (2)

Country Link
KR (1) KR100991032B1 (en)
WO (1) WO2010067986A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101154043B1 (en) 2011-07-01 2012-06-07 주식회사 에코덤 Pharmaceutical composition and food composition for preventing or improving gastro-intestinal motility disorder

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548501B2 (en) * 2000-05-31 2003-04-15 Pfizer Inc. Composition and methods for stimulating gastrointestinal motility
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548501B2 (en) * 2000-05-31 2003-04-15 Pfizer Inc. Composition and methods for stimulating gastrointestinal motility
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OK HWA JHEE ET AL.: 'Pharmacokinetic and bioequivalence evaluation of two or mulations of 100 mg trimebutine maleate (Recutin and Polybutin) in healthy male volunteers sing the LC-MS/MS method' CLIN. CHIM. ACTA. vol. 375, no. 1-2, January 2007, pages 69 - 75 *

Also Published As

Publication number Publication date
WO2010067986A3 (en) 2010-09-10
KR100991032B1 (en) 2010-10-29
KR20100065643A (en) 2010-06-17

Similar Documents

Publication Publication Date Title
WO2010027567A3 (en) Tricyclic spirocycle derivatives and methods of use thereof
CL2007003261A1 (en) COMPOUNDS DERIVED FROM 1,4-BENZOTIEPINA-1,1-DIOXIDE; PHARMACEUTICAL COMPOSITION; AND ITS USE FOR THE TREATMENT OF LIPID METABOLISM DISORDERS, HYPERLIPIDEMIA, INSULIN RESISTANCE, DIABETES AND CNS DISORDERS, SUCH AS SCHIZOPHRENIA,
WO2010123930A3 (en) Chemosensory receptor ligand-based therapies
WO2008097428A3 (en) Compounds and compositions as modulators of gpr119 activity
MX2014003579A (en) Glucagon superfamily peptides exhibiting glucocorticoid receptor activity.
MX2015001500A (en) Antidiabetic tricyclic compounds.
CL2008001126A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
EA201891432A1 (en) SUBSTITUTED 4-PHENYLPYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS
WO2007104789A3 (en) Amylin derivatives
DE602007004324D1 (en) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
CY1112398T1 (en) CYROLOXYL PYROLYLIDINE SUBSTITUTES AS 11-B-HYDROXYSTEROHYDROHYDROHOUSE INHIBITIONS 1
WO2012054526A3 (en) Chemosensory receptor ligand-based therapies
WO2013158928A3 (en) Chemosensory receptor ligand-based therapies
MX2010010407A (en) Substituted 4-aminocyclohexane derivatives.
MX2015010935A (en) Antidiabetic bicyclic compounds.
CL2010001496A1 (en) Compounds derived from (pyridin- or pyrimidin-) piperidine, gpr119 agonists; pharmaceutical composition; and its use for the treatment of type I diabetes, type II diabetes and related diseases such as metabolic syndrome, dyslipidemia and insulin resistance.
CR20110255A (en) NEW COMPOUNDS 578
WO2010127856A8 (en) Substituted phenylureas and phenylamides as vanilloid receptor ligands
EP2560660A4 (en) Chemosensory receptor ligand-based therapies
PH12015501116A1 (en) New indanyloxydihydrobenzofuranylacetic acids
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
WO2010045303A3 (en) Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
EA201100910A1 (en) TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE BETA-DEFENSINS OF MAMMALS
BR112012031873A2 (en) ccr2 cyclohexyl azetidinyl antagonists
EA201190207A1 (en) CONNECTIONS FOR THE TREATMENT OF METABOLIC DISORDERS

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09832071

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09832071

Country of ref document: EP

Kind code of ref document: A2